News

Jun 17,2020

C4 Therapeutics Raises $170 Million Financing to Bring Robust Pipeline of Protein Degraders to Clinical Proof-of-Concept and to Advance Proprietary Platform

Jun 17,2020

OncoImmune, Inc. Reports Progress on its Phase III Clinical Trial testing CD24Fc for Severe and Critical COVID-19

May 30,2020

Immune-Onc Therapeutics IND Application for First-In-Human Trial of IO-202, a Novel Antibody for the Treatment of Acute Myeloid Leukemia, Receives FDA Clearance

Apr 16,2020

Ansun Biopharma Enrolls First Patient in Proof of Concept Trial of DAS181 for the Treatment of COVID-19

Apr 09,2020

OncoImmune Receives FDA Approval for COVID-19 Clinical Trial

Apr 02,2020

Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment

Mar 26,2020

Regenacy Pharmaceuticals Raises $30 Million in Series A Financing

Mar 24,2020

Apexigen Completes $123 Million Series C Financing To Advance Clinical Pipeline

No more pages to load

Next page